Anoverview of cerebral ischemia:Cerebrovascular accident or stroke have a high global incidence.The most common types of stroke are ischemic,accounting for 87%of the total number,and they are triggered by a reduction ...Anoverview of cerebral ischemia:Cerebrovascular accident or stroke have a high global incidence.The most common types of stroke are ischemic,accounting for 87%of the total number,and they are triggered by a reduction or interruption of blood flow to the central nervous system,usually caused by a thrombus,embolus or atherosclerotic plaque.The severity of brain damage caused by this kind of stroke is directly related to the size of the vessel that is occluded and the duration of occlusion.展开更多
Cell grafting has been considered a therapeutic approach for Parkinson's disease(PD) since the 1980 s. The classical motor symptoms of PD are caused by the loss of dopaminergic neurons in the substantia nigra pars...Cell grafting has been considered a therapeutic approach for Parkinson's disease(PD) since the 1980 s. The classical motor symptoms of PD are caused by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a decrement in dopamine release in the striatum. Consequently, the therapy of celltransplantation for PD consists in grafting dopamineproducing cells directly into the brain to reestablish dopamine levels. Different cell sources have been shown to induce functional benefits on both animal models of PD and human patients. However, the observed motor improvements are highly variable between individual subjects, and the sources of this variability are not fully understood. The purpose of this review is to provide a general overview of the pioneering studies done in animal models of PD that established the basis for the first clinical trials in humans, and compare these with the latest findings to identify the most relevant aspects that remain unanswered to date. The main focus of the discussions presented here will be on the mechanisms associated with the survival and functionality of the transplants. These include the role of the dopamine released by the grafts and the capacity of the grafted cells to extend fibers and to integrate into the motor circuit. The complete understanding of these aspects will require extensive research on basic aspects of molecular and cellular physiology, together with neuronal network function, in order to uncover the real potential of cell grafting for treating PD.展开更多
基金This work was supported by grants from Spanish Ministry of Economy and Competitiveness(BFU-2008-03980,BFU2016-77885-P)from Comunidad de Madrid(S2017/BMD-3700)from Departamento de Biología,Facultad de Ciencias-UAM(BIOUAM03-2020).
文摘Anoverview of cerebral ischemia:Cerebrovascular accident or stroke have a high global incidence.The most common types of stroke are ischemic,accounting for 87%of the total number,and they are triggered by a reduction or interruption of blood flow to the central nervous system,usually caused by a thrombus,embolus or atherosclerotic plaque.The severity of brain damage caused by this kind of stroke is directly related to the size of the vessel that is occluded and the duration of occlusion.
基金Supported by DGAPA-PAPIIT,No.IN207116CONACyT,No.179927
文摘Cell grafting has been considered a therapeutic approach for Parkinson's disease(PD) since the 1980 s. The classical motor symptoms of PD are caused by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a decrement in dopamine release in the striatum. Consequently, the therapy of celltransplantation for PD consists in grafting dopamineproducing cells directly into the brain to reestablish dopamine levels. Different cell sources have been shown to induce functional benefits on both animal models of PD and human patients. However, the observed motor improvements are highly variable between individual subjects, and the sources of this variability are not fully understood. The purpose of this review is to provide a general overview of the pioneering studies done in animal models of PD that established the basis for the first clinical trials in humans, and compare these with the latest findings to identify the most relevant aspects that remain unanswered to date. The main focus of the discussions presented here will be on the mechanisms associated with the survival and functionality of the transplants. These include the role of the dopamine released by the grafts and the capacity of the grafted cells to extend fibers and to integrate into the motor circuit. The complete understanding of these aspects will require extensive research on basic aspects of molecular and cellular physiology, together with neuronal network function, in order to uncover the real potential of cell grafting for treating PD.
